Activity value 75china Supplier,Last transaction date:
2026-01-19Address: rm.1902 easey comm. bldg., 253-261 hennessy road wanchai hongkong hong,kong, , hong kong hong kong
The above chart presents the market trend analysis for wen pharmaceutical industries ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 980 and a transaction weight of 0.
Product description
COMPOSTOS HETEROCíCLICOS, EXCLUSIVAMENTE DE HETERO-áTOMO(S) DE AZOTO (NITROGéNIO)|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS HETEROCICLICOS, SEUS SAIS E SULFONAMIDAS
Expand
Product description
COMPOSTOS HETEROCíCLICOS, EXCLUSIVAMENTE DE HETERO-áTOMO(S) DE AZOTO (NITROGéNIO)|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS HETEROCICLICOS, SEUS SAIS E SULFONAMIDAS
Expand
Trade date
2025/11/01
B/L No.
——
Supplier
wen pharmaceutical industries ltd.
Buyers
pharlab industria farmaceutical s.a.
Product description
COMPOSTOS HETEROCíCLICOS, EXCLUSIVAMENTE DE HETERO-áTOMO(S) DE AZOTO (NITROGéNIO)|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS HETEROCICLICOS, SEUS SAIS E SULFONAMIDAS
Expand
Product description
HORMONAS, PROSTAGLANDINAS, TROMBOXANOS E LEUCOTRIENOS, NATURAIS OU REPRODUZIDOS POR SíNTESE; SEUS DERIVADOS E ANáLOGOS ESTRUTURAIS, INCLUINDO OS POLIPéPTIDOS DE CADEIA MODIFICADA, UTILIZADOS PRINCIPALMENTE COMO HORMONAS|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS FARMACêUTICOS, PRODUTOS QUíMICOS MEDICINAIS E BOTâNICOS|HORMONIOS NATURAIS, REPROD.POR SINTESE E SEUS DERIVADOS
Expand
wen pharmaceutical industries ltd. is china Supplier,
and primarily engages in the import and export business of products such as bma,isoamyl allyl glycolate,amino.
According to the 52wmb.com global trade database, as of 2026-01-19, the company has completed 265 international trades,
with its main trading regions covering brazil,turkey,india etc.
The core products include HS29189999,HS29339990,HS2918193000 etc,
often transported via shanghai,port beijing etc,
and its main trading partners are pharmactive il,hipolabor farmaceutica ltd.,globe chemicals g.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on wen pharmaceutical industries ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.